home / stock / iccm / iccm news


ICCM News and Press, IceCure Medical Ltd. From 11/01/21

Stock Information

Company Name: IceCure Medical Ltd.
Stock Symbol: ICCM
Market: NASDAQ
Website: icecure-medical.com

Menu

ICCM ICCM Quote ICCM Short ICCM News ICCM Articles ICCM Message Board
Get ICCM Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCM - IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense(TM)

IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense™ IceCure Medical Announces New Independent Data Published in ...

ICCM - ZEV, EBON and SELB among pre market gainers

Diginex (NASDAQ:EQOS) +70% on its crypto exchange, EQONEX listing Polkadot token on its platform Bakkt Holdings (NYSE:BKKT) +67% after agreements with Fiserv, Mastercard Wallbox (NYSE:WBX) +56% Uber and Wallbox team up on the road to zero emissions Code Chain New Continent (NAS...

ICCM - IceCure Medical, Kiromic BioPharma leads healthcare gainers; ERYTECH Pharma, Eyenovia among major losers

Gainers: IceCure Medical (NASDAQ:ICCM) +15%, Kiromic BioPharma KRBP +12%, Eargo (NASDAQ:EAR) +12%, Context Therapeutics (NASDAQ:CNTX) +11%, Xeris Biopharma XERS +11%. Losers: ERYTECH Pharma ERYP -39%, Eyenovia EYEN -37%, Es...

ICCM - FRSX, IBN and TTNP among pre market gainers

Remark Holdings (NASDAQ:MARK) +266%. Sonim Technologies (NASDAQ:SONM) +96%. Creatd (NASDAQ:CRTD) +69% announces second NFT drop, includes photographs of former President Donald Trump PAE Incorporated (NASDAQ:PAE) +67% Amentum to buy PAE in an all-cash deal valued at ~$1.9 ...

ICCM - ME, CYCN and FWBI among pre market gainers

LumiraDx (NASDAQ:LMDX) +37% after approval for COVID-19 antigen test in India Troika Media (NASDAQ:TRKA) +32%. Puhui Wealth Investment Management (NASDAQ:PHCF) +16%. Valneva  (NASDAQ:VALN) +16%. Xiaobai Maimai (NASDAQ:HX) +11%. Cyclerion Therapeutics (NASDAQ:CYCN) +11%. F-star ...

ICCM - IceCure Medical Enters into an Exclusive Agreement in Poland for Distribution of the ProSense(TM) Cryoablation System

IceCure Medical Enters into an Exclusive Agreement in Poland for Distribution of the ProSense™ Cryoablation System PR Newswire CAESAREA, Israel , Oct. 20, 2021 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), d...

ICCM - IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation

IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation IceCure submitted an amendment to the registration certificate granted for the IceSense3 System by China's NMPA, which will allow IceCure to ...

ICCM - Protagonist Therapeutics, Adamas Pharmaceuticals leads healthcare gainers; Voyager Therapeutics, Protalix BioTherapeutics among major losers

Gainers: Protagonist Therapeutics (NASDAQ:PTGX) +82%, Adamas Pharmaceuticals (NASDAQ:ADMS) +74%, Flexion Therapeutics (NASDAQ:FLXN) +62%, Evelo Biosciences (NASDAQ:EVLO) +16%, Progenity (NASDAQ:PROG) +16%. Losers: Voyager Therapeutics (NASDAQ:VYGR)...

ICCM - IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights

IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights PR Newswire CAESAREA, Israel , Sept. 23, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of the next...

ICCM - IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer

IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer Dr. Richard Fine to present findings at the Mayo Clinc Conference "Breast Cancer Care: Innovation, Disruptive Techno...

Previous 10 Next 10